ARTICLE | Clinical News
AeroGen starts AeroDose Phase II
March 13, 2001 8:00 AM UTC
AEGN began Phase II testing of ipratropium, an anticholinergic bronchodilator, delivered using the company's AeroDose aerosol inhaler to treat respiratory disorders. ...